Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Advanced Solid Tumors 27Advanced Solid Tumor 26Solid Tumor 13Solid Tumors 6Advanced Solid Tumour 5Advanced Malignant Solid Tumor 4Metastatic Solid Tumors 2Mesothelioma 2Advanced or Metastatic Solid Tumors 2mCRPC (Metastatic Castration-resistant Prostate Cancer) 1Uveal Melanoma 1Solid Tumor, Adult 1Pediatric Solid Tumor, Unspecified, Protocol Specific 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Melanoma 1Malignant Solid Tumors 1Malignant Solid Tumor 1Locally Advanced/Metastatic Solid Tumours 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Solid Tumor 1HER2-Positive Solid Tumors 1Docetaxel 1Colorectal Neoplasms 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumours 1Advanced Solid Tumors Cancer 1Advanced Solid Tumors - Phase 1 Population 1Advanced Solid Tumor (Phase 1) 1Advanced Malignant Solid Tumours 1

Interventions

Cisplatin 57Pemetrexed 46pembrolizumab 18Nivolumab 15Carboplatin 15Gemcitabine 14Cyclophosphamide 13Radiotherapy 10Drug Therapy 9atezolizumab 8Platinum 7Ipilimumab 7Doxorubicin 7durvalumab 61,2-diaminocyclohexaneplatinum II citrate 6tremelimumab 5sodium thiosulfate 5Vinorelbine 5Radiotherapy, Intensity-Modulated 5Interleukin-2 5Chemotherapy, Adjuvant 5Cerebral Decortication 5sargramostim 4fludarabine 4defactinib 4aldesleukin 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3cediranib 3Photochemotherapy 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Injections × Other solid neoplasm × Clear all
NCT04996017 2025-03-13

AtezoMeso

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 3 Recruiting
162 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡